Carroll Financial Associates Has Trimmed Its Johnson & Johnson Com (JNJ) Holding; Eventide Asset Management Upped Varonis Sys (VRNS) Stake By $18.66 Million

Varonis Systems, Inc. (NASDAQ:VRNS) Logo

Carroll Financial Associates Inc decreased Johnson & Johnson Com (JNJ) stake by 6.07% reported in 2018Q1 SEC filing. Carroll Financial Associates Inc sold 4,439 shares as Johnson & Johnson Com (JNJ)’s stock declined 8.03%. The Carroll Financial Associates Inc holds 68,689 shares with $8.80 million value, down from 73,128 last quarter. Johnson & Johnson Com now has $328.91B valuation. The stock increased 0.07% or $0.09 during the last trading session, reaching $122.63. About 5.84M shares traded. Johnson & Johnson (NYSE:JNJ) has declined 4.75% since June 14, 2017 and is downtrending. It has underperformed by 17.32% the S&P500. Some Historical JNJ News: ; 17/04/2018 – J&J 1Q ADJ EPS $2.06, EST. $2; 05/04/2018 – Johnson & Johnson Institute Adds Innovative Analytics-Based Learning Platform to Help Surgeons Improve Technical Skills and Cli; 26/04/2018 – Quandl Launches Exclusive Corporate Aviation Intelligence Platform; 01/05/2018 – Johnson & Johnson Vision Presents New Data on Silicone Hydrogel Contact Lens Muco-Adhesive Properties; 17/04/2018 – J&J – EXCLUDING NET IMPACT OF ACQUISITIONS AND DIVESTITURES, ON AN OPERATIONAL BASIS, QTRLY INTERNATIONAL SALES INCREASED 7.6%; 16/03/2018 – J&J says it’s received a $2.1 billion bid for LifeScan diabetes business; 16/03/2018 – RPT-J&J says offered $2.1 bln for Lifescan diabetes business; 25/05/2018 – CN RAIL CEO JJ RUEST SPEAKS IN BNN BLOOMBERG TV INTERVIEW; 17/04/2018 – J&J Raises Sales Forecast in Health Earnings Kick-Off (Correct); 23/03/2018 – Inside J&J’s Effort to Cut Costs and Drive Integration at Ad Firms WPP and Omnicom

Eventide Asset Management Llc increased Varonis Sys Inc (VRNS) stake by 185.12% reported in 2018Q1 SEC filing. Eventide Asset Management Llc acquired 311,000 shares as Varonis Sys Inc (VRNS)’s stock rose 35.26%. The Eventide Asset Management Llc holds 479,000 shares with $28.98 million value, up from 168,000 last quarter. Varonis Sys Inc now has $2.33 billion valuation. The stock decreased 1.10% or $0.9 during the last trading session, reaching $81. About 326,886 shares traded or 10.54% up from the average. Varonis Systems, Inc. (NASDAQ:VRNS) has risen 106.93% since June 14, 2017 and is uptrending. It has outperformed by 94.36% the S&P500. Some Historical VRNS News: ; 30/04/2018 – Varonis Systems Sees FY Rev $264M-$268.5M; 29/05/2018 – Varonis Celebrates Winners of Inaugural Channel Partner Awards; 24/05/2018 – Varonis Systems Presenting at Conference Jun 12; 30/04/2018 – Varonis Systems Sees 2Q Rev $61.5M-$62.5M; 30/04/2018 – Varonis Systems 1Q Adj Loss/Shr 22c; 29/05/2018 – Varonis to Showcase Latest Products and Host Presentations on Data-Centric Security at lnfosecurity Europe 2018; 30/05/2018 – Varonis Highlights Latest Products and Explores the Future of Cybersecurity at Gartner Security & Risk Management Summit 2018; 16/04/2018 – Varonis Systems Presenting at RSA Conference Tomorrow; 13/04/2018 – Varonis Systems Presenting at RSA Conference Apr 17; 12/03/2018 – Varonis Systems at Company Marketing Hosted By Stephens Inc

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Seekingalpha.com which released: “Recent Purchase: Johnson & Johnson” on June 14, 2018, also Seekingalpha.com with their article: “Johnson & Johnson (JNJ) Presents at Goldman Sachs 39th Annual Global Healthcare Conference Call (Transcript)” published on June 12, 2018, Fool.com published: “Better Buy: Verizon Communications Inc. vs. Johnson & Johnson” on June 11, 2018. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Seekingalpha.com and their article: “How Do You Feel About Johnson & Johnson?: Part IV – Today’s Editors’ Picks” published on June 01, 2018 as well as Livetradingnews.com‘s news article titled: “Johnson & Johnson (NYSE:JNJ) Stock Worth Watching” with publication date: June 04, 2018.

Carroll Financial Associates Inc increased Revenueshares Small Cap Etf stake by 12,175 shares to 44,227 valued at $3.00M in 2018Q1. It also upped Vanguard Short Term Corp Bond Fd Etf (VCSH) stake by 12,553 shares and now owns 83,597 shares. First Trust Capital Strength Etf (FTCS) was raised too.

Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on July, 17. They expect $2.06 earnings per share, up 12.57% or $0.23 from last year’s $1.83 per share. JNJ’s profit will be $5.53 billion for 14.88 P/E if the $2.06 EPS becomes a reality. After $2.06 actual earnings per share reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Since February 15, 2018, it had 0 insider buys, and 1 sale for $20.17 million activity. 155,342 shares were sold by Stoffels Paulus, worth $20.17 million.

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 11 have Buy rating, 5 Sell and 7 Hold. Therefore 48% are positive. Johnson & Johnson had 102 analyst reports since August 7, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Thursday, August 31 by BMO Capital Markets. As per Friday, July 14, the company rating was maintained by Jefferies. Credit Suisse upgraded Johnson & Johnson (NYSE:JNJ) rating on Thursday, April 12. Credit Suisse has “Buy” rating and $15400 target. BTIG Research maintained the shares of JNJ in report on Wednesday, August 2 with “Sell” rating. On Monday, July 10 the stock rating was maintained by RBC Capital Markets with “Buy”. The firm earned “Buy” rating on Tuesday, September 29 by Deutsche Bank. The company was upgraded on Monday, March 14 by Goldman Sachs. BMO Capital Markets maintained the stock with “Buy” rating in Tuesday, July 18 report. The rating was maintained by Cowen & Co with “Buy” on Friday, October 6. The rating was maintained by Argus Research with “Buy” on Wednesday, April 20.

Investors sentiment increased to 0.93 in Q1 2018. Its up 0.06, from 0.87 in 2017Q4. It is positive, as 63 investors sold JNJ shares while 831 reduced holdings. 111 funds opened positions while 720 raised stakes. 1.71 billion shares or 0.80% less from 1.72 billion shares in 2017Q4 were reported. Schmidt P J Inv Incorporated has 59,181 shares for 2.22% of their portfolio. Kornitzer Ks reported 1.08% stake. Fidelity Fincl, Florida-based fund reported 58,480 shares. Rock Point Advsrs Lc invested in 0.47% or 7,370 shares. Hardman Johnston Glob Advsrs Limited Liability Company reported 192,489 shares. Westwood Hldg Group Inc Inc accumulated 1.74 million shares or 1.81% of the stock. Holt Capital Advsrs Ltd Liability Dba Holt Capital Partners Ltd Partnership has 0.99% invested in Johnson & Johnson (NYSE:JNJ) for 25,225 shares. Lakeview Prtnrs Limited Liability Corporation accumulated 11,508 shares. Efg Asset Mngmt (Americas) Corp owns 4,899 shares. Winslow Evans Crocker reported 0% of its portfolio in Johnson & Johnson (NYSE:JNJ). Columbia L L C Invest Management accumulated 132,149 shares or 2.16% of the stock. At Commercial Bank holds 0.2% or 14,393 shares. Chilton Capital Ltd Co holds 95,055 shares. Jacobson Schmitt Advsrs Limited invested in 1,228 shares or 0.11% of the stock. Davidson Investment Advsr holds 1.79% or 129,886 shares in its portfolio.

Investors sentiment decreased to 0.97 in 2018 Q1. Its down 0.63, from 1.6 in 2017Q4. It is negative, as 22 investors sold VRNS shares while 66 reduced holdings. 35 funds opened positions while 50 raised stakes. 22.20 million shares or 0.63% less from 22.34 million shares in 2017Q4 were reported. Northern accumulated 246,843 shares or 0% of the stock. Guggenheim Ltd owns 4,655 shares for 0% of their portfolio. 1832 Asset Mngmt Lp accumulated 24,500 shares or 0.01% of the stock. Ardsley Advisory reported 0.09% in Varonis Systems, Inc. (NASDAQ:VRNS). Cetera Advisors Ltd Liability Com holds 4,638 shares. Qs Investors Ltd Llc holds 17,828 shares. Gsa Cap Partners Llp reported 20,659 shares. Swiss Bancorp owns 26,518 shares or 0% of their US portfolio. 28,491 are held by State Board Of Administration Of Florida Retirement System. California-based California Employees Retirement Systems has invested 0% in Varonis Systems, Inc. (NASDAQ:VRNS). Bnp Paribas Arbitrage Sa holds 0% in Varonis Systems, Inc. (NASDAQ:VRNS) or 4,142 shares. Captrust holds 0% in Varonis Systems, Inc. (NASDAQ:VRNS) or 127 shares. Timpani Capital Mgmt Limited Liability Company owns 136,374 shares. Horseman owns 20,000 shares. Schmidt P J Inv Management has invested 0.1% in Varonis Systems, Inc. (NASDAQ:VRNS).

Among 13 analysts covering Varonis Systems (NASDAQ:VRNS), 11 have Buy rating, 0 Sell and 2 Hold. Therefore 85% are positive. Varonis Systems has $8000 highest and $16 lowest target. $64.62’s average target is -20.22% below currents $81 stock price. Varonis Systems had 59 analyst reports since August 7, 2015 according to SRatingsIntel. On Tuesday, December 5 the stock rating was initiated by Oppenheimer with “Buy”. The company was maintained on Wednesday, August 10 by Jefferies. The firm has “Equal-Weight” rating given on Wednesday, June 21 by Morgan Stanley. The rating was maintained by JMP Securities on Wednesday, August 10 with “Market Outperform”. On Wednesday, June 7 the stock rating was maintained by Jefferies with “Buy”. The firm has “Buy” rating by Brean Capital given on Tuesday, January 12. The firm has “Outperform” rating by Imperial Capital given on Thursday, November 12. The rating was maintained by Needham with “Buy” on Friday, January 19. The stock of Varonis Systems, Inc. (NASDAQ:VRNS) has “Buy” rating given on Tuesday, February 13 by Stifel Nicolaus. JMP Securities maintained Varonis Systems, Inc. (NASDAQ:VRNS) rating on Tuesday, May 1. JMP Securities has “Market Outperform” rating and $71 target.

Since January 3, 2018, it had 0 insider buys, and 15 selling transactions for $34.66 million activity. $53,509 worth of Varonis Systems, Inc. (NASDAQ:VRNS) was sold by Melamed Guy on Tuesday, May 1. Faitelson Yakov sold $13.77 million worth of stock. The insider Bass David sold 17,500 shares worth $1.01M. $261,594 worth of stock was sold by Iohan Gili on Tuesday, June 5. $1.99 million worth of Varonis Systems, Inc. (NASDAQ:VRNS) was sold by O’Boyle James on Thursday, March 1. COMOLLI KEVIN E sold 50,000 shares worth $2.95 million.

Eventide Asset Management Llc decreased Acadia Pharmaceuticals Inc (NASDAQ:ACAD) stake by 221,100 shares to 113,600 valued at $2.55 million in 2018Q1. It also reduced The Trade Desk Inc stake by 329,000 shares and now owns 360,000 shares. Wave Life Sciences Ltd was reduced too.

More notable recent Varonis Systems, Inc. (NASDAQ:VRNS) news were published by: Nasdaq.com which released: “Independent Firm Finds Varonis Data Security Platform Can Deliver a 346% ROI” on June 13, 2018, also Globenewswire.com with their article: “Varonis Celebrates Winners of Inaugural Channel Partner Awards” published on May 29, 2018, Gurufocus.com published: “Varonis Systems Inc (VRNS) CEO, President, Chairman Yakov Faitelson Sold $13.8 million of Shares” on June 09, 2018. More interesting news about Varonis Systems, Inc. (NASDAQ:VRNS) were released by: Nasdaq.com and their article: “Data Protection Cited as a Top Priority for 82% of Federal Decision Makers, According to New Report” published on June 06, 2018 as well as Nasdaq.com‘s news article titled: “Varonis Highlights Latest Products and Explores the Future of Cybersecurity at Gartner Security & Risk Management …” with publication date: May 30, 2018.

Johnson & Johnson (NYSE:JNJ) Institutional Positions Chart